Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Atherosclerosis: Combating the Killer!

Genetic mutations could now be easily understood!!!

EF-TU: Travel back in time and evolve with this special protein!!!

Atherosclerosis: Combating the Killer!
  • BiotechToday
  • World

Atherosclerosis: Combating the Killer!

bioxone May 6, 2021May 6, 2021

Richismita Hazra, Amity University Kolkata

Heart disease is the leading cause of death all across the globe. It can undoubtedly be called as ‘World’s No.1 Killer’. One of the major and common causes of this killer disease is atherosclerosis. Atherosclerosis refers to the piling up of fats, cholesterol, and other substances in and on our artery walls. This assemblage is termed plaque and can cause our arteries to narrow thereby triggering blood clots. It can potentially occur in every artery of our body and cause disability or death.

According to the researchers at the University Of Virginia School Of Medicine, strengthening the fibrous caps overlying atherosclerotic plaque could be a promising way to ward off heart attacks and strokes. These fibrous caps play the role of protective shields that act like patches on a tire. It prevents the plaque from rupturing which ultimately would prevent a heart attack or a stroke. Redefining the understanding of how the protective caps form and how they attain their stability has been revealed by the scientists. This may be of immense help to doctors who could use these insights to prevent plaques from rupturing.

It was assumed in the past that most of the protective fibrous cap cells originated from smooth muscles. However, advanced research highlights the dynamic nature of this structure. Recent research suggests that up to 40% of the fibrous cells in the cap (in lab mice) are not of smooth muscle cell origin. In human lesions, approximately 20% – 25% of the fibrous cap cells do not originate from smooth muscle cells. Other sources include endothelial cells and immune cells.

This study unveils a potentially novel approach towards shrinking the probability of plaque rupture. The research team urges scientists and pharmaceutical companies to re-examine their proposition in preventing the killer disease.

Also read:Genetic mutations could now be easily understood!!!

Source: Newman, A.A.C., et al. (2021) Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRβ and bioenergetic mechanisms. Nature Metabolism. doi.org/10.1038/s42255-020-00338-8.

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged arteries atherosclerosis blood flow cells cholesterol death dynamic fats fibrous cap heart heart attack heart disease lesions muscle cells plaques rupture smooth muscle cells stroke treatment

One thought on “Atherosclerosis: Combating the Killer!”

  1. Pingback: EF-TU: Travel back in time and evolve with this special protein!!! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India

EF-TU: Travel back in time and evolve with this special protein!!!

bioxone May 7, 2021

Anannya Roy, Amity University Kolkata One of the main functions a cell performs is the synthesis of proteins. This is done with the help of a set of factors called “transcription factors”. A team of researchers from Uppasala University have succeeded in studying transcription factors that are several billion years old. The studies helped them […]

EF-TU

Related Post

  • BiotechToday
  • World

The curious case of Covid-19 Re-infection

bioxone June 22, 2021June 21, 2021

Madhavi Bhatia, NIPER Guwahati Coronavirus infection recovery provides a significant amount of immunity to individuals but there are some cases that have revealed that even after successfully recovering from COVID-19 infection there are chances of re-infection. This is mainly found to be due to mutation in the virus leading to different variants like alpha and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Chronic Fatigue Syndrome: Post-exertional Malaise studies

bioxone September 28, 2020September 28, 2020

BISWADEEP SEN, AMITY UNIVERSITY KOLKATA Persistent fatigue, increasing exercise intolerance, cognitive difficulties, or joint pain are the main symptoms of Post-exertional malaise. It is the pivotal reason for ME /Chronic Fatigue Syndrome. 43 patients were subjected to a Cardiopulmonary exercise test and the data was categorized systematically for analysis. In CPET, the patients have to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Effect of the double mutant variant of COVID 19

bioxone March 31, 2021March 31, 2021

Sampriti Roy, University of Calcutta Coronavirus yet again presents new issues to worry about this year, aside from the devastating global pandemic it has caused. Over the last few weeks, a new “double mutant variant” has been detected in some pockets of India, particularly Delhi and Maharashtra. This “double mutant” strain has been found in […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy